Type 1 Diabetes

Adults who were exposed to higher levels of endocrine-disrupting chemicals were more likely to be diagnosed with thyroid cancer, according to a study published in eBioMedicine.

A Janus kinase inhibitor may preserve beta-cell function for children and young adults recently diagnosed with type 1 diabetes, according to findings published in The New England Journal of Medicine.

Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP, about nuances of using SGLT2 inhibitors and GLP-1 receptor agonists in type 1 diabetes, and a therapy for delaying type 1 diabetes onset.

Children and adults using a hybrid closed-loop insulin delivery system had fewer cases of severe hypoglycemia and diabetic ketoacidosis than what was previously observed in historical data, according to study findings.

Children with type 1 diabetes living in small or isolated rural towns are less likely to use continuous glucose monitoring than those living in urban areas, according to data published in Diabetes Care.

Mean HbA1c for children and adults with type 1 diabetes improved by 0.3 percentage points from 2016 to 2022, according to data from 15 clinics participating in the T1D Exchange Quality Improvement Collaborative.

Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Erin Phillips, MPH, RD, CDCES, about how diabetes care and education specialists can address the risk for eating disorders after a diagnosis of type 1 diabetes.

Children with new-onset type 1 diabetes had better preservation of beta-cell function with two 12-day courses of teplizumab compared with those receiving placebo, according to findings published in The New England Journal of Medicine.

It is not uncommon for endocrinologists to treat adults with both diabetes and thyroid disease.

Children and adolescents with type 1 diabetes had an increase in time in range and reduction in HbA1c after starting a tubeless hybrid closed-loop insulin delivery system, according to study data